Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.11.060
PubMed Identifier: 32005538
Publication URI: http://europepmc.org/abstract/MED/32005538
Type: Journal Article/Review
Volume: 38
Parent Publication: Vaccine
Issue: 9
ISSN: 0264-410X